What does CUSIP 23343Q100 represent in this 13F holders report?

CUSIP 23343Q100 is the security identifier for DFPH - Oncology Institute, Inc. - Common used to aggregate holder disclosures.

How many institutions held DFPH - Oncology Institute, Inc. - Common in Q4 2022?

1 institutional investor reported DFPH - Oncology Institute, Inc. - Common for Q4 2022. Use the holders table for investor-level position and value details.

Oncology Institute, Inc. - Common (DFPH)

CUSIP: 23343Q100

Q4 2022 13F Holders as of 31 Dec 2022

Security type / class: Equity / Common
Total 13F shares: 9
Total 13F value: $15
Share change: +9
SEC-reported price per share: $1.67
Number of holders: 1
Value change: +$15
Number of buys: 1
Shares outstanding: 98,364,308

Security key

23343Q100

Report period

Q4 2022

Institutions

Top holders

DFPH full security history Ownership snapshot Full 13F holder table Newer quarter: Q1 2023 Previous quarter: Q4 2021 Oncology Institute, Inc. SEC filings Oncology Institute, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 23343Q100

Newer quarter: Q1 2023 Previous quarter: Q4 2021

Recent filing periods:

Q1 2023 Q4 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021 Q4 2020 Q3 2020

Ownership snapshot

Top reported holders of DFPH - Oncology Institute, Inc. - Common (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

FMR LLC

Disclosed value leader

FMR LLC

Comparable rows

15/15

Latest evidence

30 Sep 2022

13F Lead comparable stake: 12% Showing 1-6 of 15 holder rows.

Quick read

FMR LLC leads the comparable SEC ownership view at 12%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Comparable ownership Top 5

FMR LLC 12%

VANGUARD GROUP INC 1.8%

Redmile Group, LLC 1.6%

BlackRock Finance, Inc. 1.5%

Velan Capital Investment Manageme... 0.54%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
FMR LLC	13F Company 13F	12%	$55,561,000 12,000,269 shares	—	30 Sep 2022
VANGUARD GROUP INC	13F Company 13F	1.8%	$8,613,000 1,860,242 shares	—	30 Sep 2022
Redmile Group, LLC	13F Company 13F	1.6%	$7,330,000 1,583,158 shares	—	30 Sep 2022
BlackRock Finance, Inc.	13F Company 13F	1.5%	$7,083,000 1,529,650 shares	—	30 Sep 2022
Velan Capital Investment Management LP	13F Company 13F	0.54%	$2,541,000 548,841 shares	—	30 Sep 2022
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	0.51%	$2,413,000 521,298 shares	—	30 Sep 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2022 vs Q4 2021 Across Filers

Q4 2021 holders

Q4 2022 holders

Holder diff

Investor	Q4 2021 Shares	Q4 2022 Shares	Share Diff	Share Chg %	Q4 2021 value	Q4 2022 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend